No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs191658572 |
chr5:61427200-61427201 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs560353181 |
chr5:61427290-61427291 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs137961959 |
chr5:61427293-61427294 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs183564522 |
chr5:61427317-61427318 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs564643176 |
chr5:61427334-61427335 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs1508894 |
chr5:61427338-61427339 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
7 |
rs547120934 |
chr5:61427345-61427346 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs79951848 |
chr5:61427350-61427351 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs188000100 |
chr5:61427407-61427408 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs192828880 |
chr5:61427504-61427505 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs570229623 |
chr5:61427552-61427553 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs78180771 |
chr5:61427584-61427585 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs183931441 |
chr5:61427601-61427602 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs186770412 |
chr5:61427655-61427656 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs116894629 |
chr5:61427660-61427661 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs554710447 |
chr5:61427687-61427688 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs573856476 |
chr5:61427701-61427702 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs551938042 |
chr5:61427735-61427736 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs143440347 |
chr5:61427791-61427792 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs570547581 |
chr5:61427816-61427817 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs75281937 |
chr5:61427840-61427841 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs544815124 |
chr5:61427847-61427848 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs147131033 |
chr5:61427857-61427858 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs531173327 |
chr5:61427864-61427865 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs192604541 |
chr5:61427882-61427883 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs547349252 |
chr5:61427902-61427903 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs560757550 |
chr5:61427928-61427929 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs140278656 |
chr5:61427945-61427946 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs141589841 |
chr5:61427946-61427947 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs116693389 |
chr5:61427961-61427962 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs112403767 |
chr5:61427970-61427971 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs150903306 |
chr5:61428003-61428004 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs114065431 |
chr5:61428028-61428029 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs139378573 |
chr5:61428080-61428081 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs1423127 |
chr5:61428137-61428138 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
36 |
rs75697640 |
chr5:61428150-61428151 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs568327803 |
chr5:61428180-61428181 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs537457677 |
chr5:61428208-61428209 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs150025687 |
chr5:61428252-61428253 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs575973638 |
chr5:61428257-61428258 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs184848312 |
chr5:61428258-61428259 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs190495109 |
chr5:61428275-61428276 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs181802253 |
chr5:61428278-61428279 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs540735635 |
chr5:61428287-61428288 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs138058867 |
chr5:61428377-61428378 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs185125547 |
chr5:61428396-61428397 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs189757588 |
chr5:61428422-61428423 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs561052313 |
chr5:61428432-61428433 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs543450883 |
chr5:61428482-61428483 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs563961985 |
chr5:61428488-61428489 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|